000			01932 a2200493 4500
005			20250517015311.0
264		0	_c20160125
008			201601s 0 0 eng d
022			_a1435-4373
024	7		_a10.1007/s10096-015-2338-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aVárkonyi, I
245	0	0	_aA part-randomized study of intravenous oseltamivir in adolescents and adults. _h[electronic resource]
260			_bEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _cJun 2015
300			_a1181-8 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aBlood Chemical Analysis
650	0	4	_aCritical Illness
650	0	4	_aDrug-Related Side Effects and Adverse Reactions _xepidemiology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInfluenza, Human _xdrug therapy
650	0	4	_aInfusions, Intravenous _xadverse effects
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNasal Mucosa _xvirology
650	0	4	_aOseltamivir _xadministration & dosage
650	0	4	_aProspective Studies
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction
650	0	4	_aTreatment Outcome
650	0	4	_aVirus Cultivation
650	0	4	_aVirus Shedding
650	0	4	_aYoung Adult
700	1		_aChappey, C
700	1		_aGiraudon, M
700	1		_aBurleigh, L
773	0		_tEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _gvol. 34 _gno. 6 _gp. 1181-8
856	4	0	_uhttps://doi.org/10.1007/s10096-015-2338-5 _zAvailable from publisher's website
999			_c24619778 _d24619778